Single-dose tolerance to antinociception, and physical dependence on beta-endorphin in mice

Eur J Pharmacol. 1978 Nov 15;52(2):179-89. doi: 10.1016/0014-2999(78)90204-2.

Abstract

beta-Endorphin (B-EN) injected intracerebroventricularly in mice produced a rapid onset, dose-dependent antinociceptive effect. The median analgesic dose (AD50) 30 min following administration was found to be 270 ng/mouse (3.7 nmoles/kg). B-EN produced an acute, single-dose tolerance which was characterized by its dose dependence and the time course of its development. Single-dose tolerance development was demonstrable with doses twice or more the AD50. Tolerance was maximal at about 12 h following the priming dose and disappeared within 48 h. Tolerance was accompanied by some degree of physical dependence as noted by signs of naloxone-precipitated withdrawal similar to those elicitable in the morphine-dependent state. Tolerance development to B-EN was blocked by the simultaneous administration of naloxone and also by pretreatment with 0.35 mg/kg actinomycin D or 30 mg/kg cycloheximide 30 min before B-EN. It appears that single-dose tolerance to B-EN was initiated by processes similar to those involved with tolerance resulting from chronic administration of morphine.

MeSH terms

  • Analgesics*
  • Animals
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Drug Tolerance
  • Endorphins / pharmacology*
  • Humans
  • Male
  • Mice
  • Mice, Inbred ICR
  • Naloxone / pharmacology
  • Rats
  • Substance-Related Disorders / etiology*
  • Time Factors

Substances

  • Analgesics
  • Endorphins
  • Dactinomycin
  • Naloxone
  • Cycloheximide